Hearing Impairment, Strategies and Outcomes in VA Emergency Departments
HearVA-ED
Implementing HearVA (I-HearVA)
2 other identifiers
interventional
1,050
1 country
6
Brief Summary
HearVA involves six VA facility emergency departments (ED) over a 3-year intervention period. The first part of this study will test whether providing personal amplifiers to Veteran ED patients who self-report hearing difficulty is acceptable to these patients, can improve their hearing, enhance understanding of discharge instructions, and can reduce the risk of coming back to the ED in a short period of time (3 days and 30 days). The second part of the study will then identify whether ED staff can implement this program and achieve similar results. The second part will give ED staff increasing levels of responsibility for screening Veterans for hearing difficulty and providing personal amplifiers when such difficulty is detected.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2021
Longer than P75 for not_applicable
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 24, 2021
CompletedFirst Posted
Study publicly available on registry
August 31, 2021
CompletedStudy Start
First participant enrolled
December 8, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 30, 2026
October 21, 2025
October 1, 2025
4.8 years
August 24, 2021
October 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
ED 3-day Readmissions
The Investigators will determine whether patients have had an ED revisit within three days through CPRS review as well as a brief follow-up phone call 3-5 days after ED discharge
3-5 days after initial ED stay
Secondary Outcomes (4)
ED 30-day Readmissions
30-35 days after initial ED stay
Patient-Rated Quality of Hearing, Understanding, and Communication With Providers During ED Stay
Duration of ED stay, average of 1 day
Patient-Rated Quality of Post-Discharge Care
At time of discharge from ED, average 1 day
Self-Reported Understanding of Discharge Instructions
3-5 days after initial ED stay
Study Arms (2)
Intervention: Personal Amplifier
EXPERIMENTALConsenting participants will be randomly assigned to the intervention group while receiving care in the emergency department
Control: No Personal Amplifier
OTHERConsenting participants will be randomly assigned to the control group while receiving care in the emergency department
Interventions
The intervention group will receive personal amplifiers (PockeTalkers) while they receive care in the ED
The control group will not receive personal amplifiers while they receive care in the ED
Eligibility Criteria
You may qualify if:
- English speaking
- Emergency severity index criterion of 3 (medium), 4, or 5 (low acuity)
- Hearing Handicap Inventory-Screen greater than or equal to 10 or positive answer to a single-item screening question
- Capacity to consent to participate in research
You may not qualify if:
- Inability to consent to participate in research
- Emergency severity index criterion of 1-2 (high acuity)
- Hearing Handicap Inventory-Screen less than 10 and negative answer to single item screening question
- Inability to speak English
- Using cochlear implants
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- VA Office of Research and Developmentlead
- NYU Langone Healthcollaborator
Study Sites (6)
Rocky Mountain Regional VA Medical Center, Aurora, CO
Aurora, Colorado, 80045-7211, United States
VA NY Harbor Healthcare System, New York, NY
New York, New York, 10010-5011, United States
Syracuse VA Medical Center, Syracuse, NY
Syracuse, New York, 13210, United States
James J. Peters VA Medical Center, Bronx, NY
The Bronx, New York, 10468, United States
Durham VA Medical Center, Durham, NC
Durham, North Carolina, 27705-3875, United States
VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX
Dallas, Texas, 75216, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joshua Chodosh, MD MSHS
VA NY Harbor Healthcare System, New York, NY
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 24, 2021
First Posted
August 31, 2021
Study Start
December 8, 2021
Primary Completion (Estimated)
September 30, 2026
Study Completion (Estimated)
September 30, 2026
Last Updated
October 21, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share